AI in Personalized Medicines: Opportunities and Challenges

The integration of Artificial Intelligence (AI) in personalized medicine has revolutionized healthcare by enabling precise, data-driven, and patient-specific treatment strategies. Artificial intelligence (AI) has the potential to revolutionize healthcare by enabling personalized medicine and improving disease diagnosis. AI-powered algorithms, particularly those leveraging machine learning (ML) and deep learning (DL), have enhanced the ability to analyse vast datasets, uncover hidden patterns, and generate predictive models that facilitate early disease detection, drug discovery, and customized treatment regimens. Emerging technologies such as explainable AI (XAI) aim to enhance transparency in decision-making, allowing physicians and patients to better understand AI-generated recommendations. The convergence of AI with other innovations, such as blockchain for secure data management and the Internet of Medical Things (IoMT) for real-time patient monitoring, further strengthens its role in personalized medicine. In 2019, the International Consortium for Personalised Medicine (ICPerMed) developed a vision on how the use of personalized medicine (PM) approaches will promote “next-generation” medicine in 2030 more firmly centred on the individual’s personal characteristics, leading to improved health outcomes within sustainable healthcare systems through research, development, innovation, and implementation for the benefit of patients, citizens, and society. This includes engagement strategies, collaboration frameworks, infrastructure development, education and training programs, ethical considerations, resource allocation guidelines, regulatory compliance, and data management and privacy. This paper explores the transformative potential of AI in personalized medicine, analysing its key applications, limitations, and future prospects. A thorough examination of current AI-driven methodologies, case studies, and policy considerations will provide a holistic understanding of the evolving landscape.

Authors

Institutions

Publication Details

Journal
Journal of Drug Discovery and Health Sciences
Published
2025-06-29
DOI
https://doi.org/10.21590/jddhs.02.02.08
Citations
1
Primary Topic
Computational Drug Discovery Methods
Type
article
Field-Weighted Citation Impact
1.50
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

AI in Personalized Medicines: Opportunities and Challenges

Anurag Sharma, Akash Ved, Neelkanth M. Pujari, Ayushi Gupta
1 citations
Journal of Drug Discovery and Health Sciences
Computational Drug Discovery Methods
1.50
article

AI in Personalized Medicines: Opportunities and Challenges

Anurag Sharma, Akash Ved, Neelkanth M. Pujari, Ayushi Gupta
article en
1 citations

Abstract

The integration of Artificial Intelligence (AI) in personalized medicine has revolutionized healthcare by enabling precise, data-driven, and patient-specific treatment strategies. Artificial intelligence (AI) has the potential to revolutionize healthcare by enabling personalized medicine and improving disease diagnosis. AI-powered algorithms, particularly those leveraging machine learning (ML) and deep learning (DL), have enhanced the ability to analyse vast datasets, uncover hidden patterns, and generate predictive models that facilitate early disease detection, drug discovery, and customized treatment regimens. Emerging technologies such as explainable AI (XAI) aim to enhance transparency in decision-making, allowing physicians and patients to better understand AI-generated recommendations. The convergence of AI with other innovations, such as blockchain for secure data management and the Internet of Medical Things (IoMT) for real-time patient monitoring, further strengthens its role in personalized medicine. In 2019, the International Consortium for Personalised Medicine (ICPerMed) developed a vision on how the use of personalized medicine (PM) approaches will promote “next-generation” medicine in 2030 more firmly centred on the individual’s personal characteristics, leading to improved health outcomes within sustainable healthcare systems through research, development, innovation, and implementation for the benefit of patients, citizens, and society. This includes engagement strategies, collaboration frameworks, infrastructure development, education and training programs, ethical considerations, resource allocation guidelines, regulatory compliance, and data management and privacy. This paper explores the transformative potential of AI in personalized medicine, analysing its key applications, limitations, and future prospects. A thorough examination of current AI-driven methodologies, case studies, and policy considerations will provide a holistic understanding of the evolving landscape.

Journal of Drug Discovery and Health SciencesVol. 2(02)
Dr. A.P.J. Abdul Kalam Technical University (IN)
Openalex Percentile: Top 14%
Computational Drug Discovery Methods
1.50
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.